Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cirtuvivint in Advanced Soft-Tissue Sarcomas
NCT07032285Phase 2Recruiting
- Sponsor
- SELNET
- Start
- Jan 2025
- Primary completion
- Apr 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cirtuvivint in soft tissue sarcoma (STS), sponsored by SELNET. Started Jan 2025; status: recruiting.
02
Drugs
cirtuvivint
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT07032285.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07032285.